Advances in Granuloma Annulare Treatment: Effectiveness and Limitations Revealed

Granuloma annulare (GA) is a benign, self-limiting skin condition characterized by annular plaques, often confused with other dermatological disorders. Although GA typically resolves spontaneously, its chronic nature can prompt patients to seek treatment. Recent advances in understanding the pathogenesis of GA have led to a variety of new therapeutic approaches. This article reviews the latest evidence on effective treatments and highlights those that have shown limited success. Current Understanding of Granuloma Annulare Granuloma annulare is thought to represent a hypersensitivity reaction, possibly triggered by factors such as infections, medications, or vaccinations. It predominantly affects children and young adults but can occur in individuals of any age. While the condition is generally asymptomatic, its aesthetic impact can significantly affect patients' quality of life. Effective Treatment Options Several treatment modalities have been explored for granuloma annulare, with varying degrees of effectiveness: Topical Corticosteroids: These are often the first-line therapy for localized GA. Studies have shown that high-potency topical corticosteroids can reduce inflammation and hasten the resolution of lesions. Intralesional Steroid Injections: For more resistant cases, intralesional injections of corticosteroids can be effective. This approach allows direct delivery of the medication into the lesion, resulting in quicker improvement. Phototherapy: Narrowband ultraviolet B (NB-UVB) therapy has gained traction as a treatment modality. Research indicates that it can promote healing in patients with widespread or recalcitrant GA. Oral Medications: Systemic treatments, including oral corticosteroids and antimalarials like hydroxychloroquine, have been used for severe cases, although their long-term safety and efficacy require more investigation. Emerging Therapies Recent studies are exploring novel therapies for granuloma annulare, including: Biologics: Agents such